Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SNB-101 by SN BioScience for Rectal Cancer: Likelihood of Approval
SNB-101 is under clinical development by SN BioScience and currently in Phase I for Rectal Cancer. According to GlobalData, Phase...
SNB-101 by SN BioScience for Head And Neck Cancer: Likelihood of Approval
SNB-101 is under clinical development by SN BioScience and currently in Phase I for Head And Neck Cancer. According to...
SNB-101 by SN BioScience for Breast Cancer: Likelihood of Approval
SNB-101 is under clinical development by SN BioScience and currently in Phase I for Breast Cancer. According to GlobalData, Phase...
SNB-101 by SN BioScience for Gastric Cancer: Likelihood of Approval
SNB-101 is under clinical development by SN BioScience and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
SNB-101 by SN BioScience for Non-Small Cell Lung Cancer: Likelihood of Approval
SNB-101 is under clinical development by SN BioScience and currently in Phase I for Non-Small Cell Lung Cancer. According to...
SNB-101 by SN BioScience for Colorectal Cancer: Likelihood of Approval
SNB-101 is under clinical development by SN BioScience and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
SNB-101 by SN BioScience for Small-Cell Lung Cancer: Likelihood of Approval
SNB-101 is under clinical development by SN BioScience and currently in Phase I for Small-Cell Lung Cancer. According to GlobalData,...
SNB-101 by SN BioScience for Pancreatic Cancer: Likelihood of Approval
SNB-101 is under clinical development by SN BioScience and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...